Armistice Capital »

Pilgrim's Pride Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Pilgrim's Pride Corporation (PPC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Pilgrim's Pride Corporation

Tip: Access up to 7 years of quarterly data

All positions including Pilgrim's Pride Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pilgrim's Pride Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $213k 7.6k 28.11
2022-03-31 $7.5M 300k 25.10

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Pilgrim's Pride Corporation

BlackRock
D. E. Shaw & Co
Dimensional Fund Advisors
Vanguard Portfolio Management
AQR Capital Management
Vanguard Capital Management
Goldman Sachs Group
Carrhae Capital
State Street Corporation
Van Eck Associates Corp.
Morgan Stanley
Assetmark
Gotham Asset Management
Geode Capital Management
Citadel Advisors

View all funds holding Pilgrim's Pride Corporation